Diabetic Endovascular Disease: Role of Coronary Artery Revascularization

American Journal of Cardiology

Volumn 99, Issue 4 SUPPL., 2007, Pages 105-112

  Stone, Kenneth E ^a   Chiquette, Elaine ^b   Chilton, Robert J ^b  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLITAZONE DERIVATIVE; PACLITAXEL; RAPAMYCIN;

ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING STENT; ENDOTHELIAL DYSFUNCTION; EXERCISE TEST; FIBRINOLYSIS; HEART EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; IN-STENT RESTENOSIS; LIFESTYLE MODIFICATION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; VASA VASORUM; VASCULAR ENDOTHELIUM;

CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; DIABETIC ANGIOPATHIES; HUMANS; MYOCARDIAL REVASCULARIZATION; REOPERATION; STENTS;

EID: 33846920907     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.11.024     Document Type: Article

References (55)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. Fox C.S., Coady S., Sorlie P.D., Levy D., Meigs J.B., D'Agostino Sr. R.B., Wilson P.W., and Savage P.J. Trends in cardiovascular complications of diabetes. JAMA 292 (2004) 2495-2499
3. Niakan E., Harati Y., Rolak L.A., Comstock J.P., and Rokey R. Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy. Arch Intern Med 146 (1986) 2229-2230
4. Kannel W.B., and Abbott R.D. Incidence and prognosis of unrecognized myocardial infarction: an update on the Framingham study. N Engl J Med 311 (1984) 1144-1147
5. Nesto R.W., Phillips R.T., Kett K.G., Hill T., Perper E., Young E., and Leland Jr. O.S. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. Ann Intern Med 108 (1988) 170-175
6. Wackers F.J., Young L.H., Inzucchi S.E., Chyun D.A., Davey J.A., Barrett E.J., Taillefer R., Wittlin S.D., Heller G.V., Filipchuk N., et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27 (2004) 1954-1961
7. Scognamiglio R., Negut C., Ramondo A., Tiengo A., and Avogaro A. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 47 (2006) 65-71
8. Hu F.B., Stampfer M.J., Solomon C., Liu S., Colditz G.A., Speizer F.E., Willett W.C., and Manson J.E. Physical activity and risk for cardiovascular events in diabetic women. Ann Intern Med 134 (2001) 96-105
9. Maiorana A., O'Driscoll G., Cheetham C., Dembo L., Stanton K., Goodman C., Taylor R., and Green D. The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes. J Am Coll Cardiol 38 (2001) 860-866
10. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 (1993) 434-444
11. Turner R.C., Millns H., Neil H.A., Stratton I.M., Manley S.E., Matthews D.R., and Holman R.R. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 316 (1998) 823-828
12. Faglia E., Manuela M., Antonella Q., Michela G., Vincenzo C., Maurizio C., Roberto M., and Alberto M. Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study. Am Heart J 149 (2005) e1-e6
13. Smith Jr. S.C., Allen J., Blair S.N., Bonow R.O., Brass L.M., Fonarow G.C., Grundy S.M., Hiratzka L., Jones D., Krumholz H.M., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113 (2006) 2363-2372
14. American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care 29 suppl (2006) S4-S42
15. Guyton J.R., and Klemp K.F. Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol 16 (1996) 4-11
16. Kruth H.S. Localization of unesterified cholesterol in human atherosclerotic lesions: demonstration of filipin-positive, oil-red-O-negative particles. Am J Pathol 114 (1984) 201-208
17. Marfella R., Di Filippo C., Baldi A., Siniscalchi M., Sasso F.C., Crescenzi B., Cirillo F., Nicoletti G.F., D'Andrea F., Chiorazzo G., et al. The vascular smooth muscle cells apoptosis in asymptomatic diabetic carotid plaques: role of glycemic control. J Am Coll Cardiol 47 (2006) 2118-2120
18. Kockx M.M., De Meyer G.R., Muhring J., Jacob W., Bult H., and Herman A.G. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 97 (1998) 2307-2315
19. Burke A.P., Farb A., Malcom G.T., Liang Y., Smialek J.E., and Virmani R. Plaque rupture and sudden death related to exertion in men with coronary artery disease. JAMA 281 (1999) 921-926
20. Mofidi R., Crotty T.B., McCarthy P., Sheehan S.J., Mehigan D., and Keaveny T.V. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Br J Surg 88 (2001) 945-950
21. Barger A.C., Beeuwkes III R., Lainey L.L., and Silverman K.J. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 310 (1984) 175-177
22. Kolodgie F.D., Gold H.K., Burke A.P., Fowler D.R., Kruth H.S., Weber D.K., Farb A., Guerrero L.J., Hayase M., Kutys R., et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349 (2003) 2316-2325
23. Kakadiaris I., Bandekar A., Gul K., Mao S.S., Takasu J., Budoff M., and Naghavi M. Automated pericardial fat quantification in CT data [abstract]. J Am Coll Cardiol 47 (2006) 264A
24. Mak K.H., Moliterno D.J., Granger C.B., Miller D.P., White H.D., Wilcox R.G., Califf R.M., Topol E.J., and GUSTO-I [Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries] Investigators. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. J Am Coll Cardiol 30 (1997) 171-179
25. Goraya T.Y., Leibson C.L., Palumbo P.J., Weston S.A., Killian J.M., Pfeifer E.A., Jacobsen S.J., Frye R.L., and Roger V.L. Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol 40 (2002) 946-953
26. Proudfoot D., Davies J.D., Skepper J.N., Weissberg P.L., and Shanahan C.M. Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. Circulation 106 (2002) 3044-3050
27. Kornowski R., Mintz G.S., Lansky A.J., Hong M.K., Kent K.M., Pichard A.D., Satler L.F., Popma J.J., Bucher T.A., and Leon M.B. Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients. Am J Cardiol 81 (1998) 1298-1304
28. Flaherty J.D., and Davidson C.J. Diabetes and coronary revascularization. JAMA 293 (2005) 1501-1508
29. Kip K.E., Faxon D.P., Detre K.M., Yeh W., Kelsey S.F., and Currier J.W. Coronary angioplasty in diabetic patients: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 94 (1996) 1818-1825
30. Sousa J.E., Serruys P.W., and Costa M.A. New frontiers in cardiology: drug-eluting stents: part I. Circulation 107 (2003) 2274-2279
31. Corpus R.A., George P.B., House J.A., Dixon S.R., Ajluni S.C., Devlin W.H., Timmis G.C., Balasubramaniam M., and O'Neill W.W. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 43 (2004) 8-14
32. Takagi T., Yamamuro A., Tamita K., Yamabe K., Katayama M., Mizoguchi S., Ibuki M., Tani T., Tanabe K., Nagai K., et al. Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study [clinical investigation]. Am Heart J 146 (2003) E5
33. Choi D., Kim S.K., Choi S.H., Ko Y.G., Ahn C.W., Jang Y., Lim S.K., Lee H.C., and Cha B.S. Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes. Diabetes Care 27 (2004) 2654-2660
34. Osman A., Otero J., Brizolara A., Waxman S., Stouffer G., Fitzgerald P., and Uretsky B.F. Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes [clinical investigation]. Am Heart J 147 (2004) e23
35. Cutlip D., and Baim D.S. Drug eluting intracoronary stents to prevent restenosis. In: Rose B.D. (Ed). UpToDate (2006), UpToDate, Waltham, MA
36. Stettler C., Allemann S., Egger M., Windecker S., Meier B., and Diem P. Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials. Heart 92 (2006) 650-657
37. Sousa J.E., Serruys P.W., and Costa M.A. New frontiers in cardiology: drug-eluting stents: part II. Circulation 107 (2003) 2383-2389
38. Powell B.D., Rihal C.S., Bell M.R., Zehr K.J., and Holmes Jr. D.R. Anticipated impact of drug-eluting stents on referral patterns for coronary artery bypass graft surgery: a population-based angiographic analysis. Mayo Clin Proc 79 (2004) 769-772
39. BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 35 (2000) 1122-1129
40. Roiron C., Sanchez P., Bouzamondo A., Lechat P., and Montalescot G. Drug eluting stents: an updated meta-analysis of randomized controlled trials. Heart 92 (2006) 641-649
41. Kastrati A., Dibra A., Mehilli J., Mayer S., Pinieck S., Pache J., Dirschinger J., and Schomig A. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 113 (2006) 2293-2300
42. Berenguer A., Mainar V., Bordes P., Valencia J., Gomez S., and Lozano T. Incidence and predictors of restenosis after sirolimus-eluting stent implantation in high-risk patients. Am Heart J 150 (2005) 536-542
43. Migliorini A., Shehu M., Carrabba N., Giurlani L., Valenti R., Buonamici P., Dovellini E.V., Parodi G., and Antoniucci D. Predictors of outcome after sirolimus-eluting stent implantation for complex in-stent restenosis. Am J Cardiol 96 (2005) 1110-1112
44. Yang T.H., Park S.W., Hong M.K., Park D.W., Park K.M., Kim Y.H., Han K.H., Lee C.W., Cheong S.S., Kim J.J., and Park S.J. Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era. Am J Cardiol 96 (2005) 1389-1392
45. Scheen A.J., Warzee F., and Legrand V.M. Drug-eluting stents: meta-analysis in diabetic patients. Eur Heart J 25 (2004) 2167-2168
46. Schampaert E., Cohen E.A., Schluter M., Reeves F., Traboulsi M., Title L.M., Kuntz R.E., and Popma J.J. The Canadian Study of the Sirolimus-Eluting Stent in the Treatment of Patients with Long De Novo Lesions in Small Native Coronary Arteries (C-SIRIUS). J Am Coll Cardiol 43 (2004) 1110-1115
47. Sousa J.E., Costa M.A., Farb A., Abizaid A., Sousa A., Seixas A.C., da Silva L.M., Feres F., Pinto I., Mattos L.A., and Virmani R. Images in cardiovascular medicine. Vascular healing 4 years after the implantation of sirolimus-eluting stent in humans: a histopathological examination. Circulation 110 (2004) e5-e6
48. Guagliumi G., Farb A., Musumeci G., Valsecchi O., Tespili M., Motta T., and Virmani R. Images in cardiovascular medicine. Sirolimus-eluting stent implanted in human coronary artery for 16 months: pathological findings. Circulation 107 (2003) 1340-1341
49. McFadden E.P., Stabile E., Regar E., Cheneau E., Ong A.T., Kinnaird T., Suddath W.O., Weissman N.J., Torguson R., Kent K.M., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521
50. Abizaid A., Costa M.A., Centemero M., Abizaid A.S., Legrand V.M., Limet R.V., Schuler G., Mohr F.W., Lindeboom W., Sousa A.G., et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 104 (2001) 533-538
51. Macaya C., Garcia H., Serruys P., Morice M.C., Legrand V., Kuck K.H., Sheiban I., Suttorp M.J., Puel J., and Vrolix M. Sirolimus-eluting stents versus surgery and bare metal stenting in the treatment of diabetic patients with multivessel disease: a comparison between ARTS I and ARTS II [abstract]. Circulation 112 (2005) II-655
52. Fuchs S., Stabile E., Kinnaird T.D., Mintz G.S., Gruberg L., Canos D.A., Pinnow E.E., Kornowski R., Suddath W.O., Satler L.F., et al. Stroke complicating percutaneous coronary interventions: incidence, predictors, and prognostic implications. Circulation 106 (2002) 86-91
53. Peel G.K., Stamou S.C., Dullum M.K., Hill P.C., Jablonski K.A., Bafi A.S., Boyce S.W., Petro K.R., and Corso P.J. Chronologic distribution of stroke after minimally invasive versus conventional coronary artery bypass. J Am Coll Cardiol 43 (2004) 752-756
54. Eagle K.A., Guyton R.A., Davidoff R., Edwards F.H., Ewy G.A., Gardner T.J., Hart J.C., Herrmann H.C., Hillis L.D., Hutter Jr. A.M., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110 (2004) e340-e437
55. Kapur A., Malik I.S., Bagger J.P., Anderson J.R., Kooner J.S., Thomas M., Punjabi P., Mayet J., Millane T., Goedicke J., et al. The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design. Am Heart J 149 (2005) 13-19